Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline
Matthew M. Davis*, Amy T. Butchart, John R C Wheeler, Margaret S. Coleman, Dianne C. Singer, Gary L. Freed
Dive into the research topics of 'Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline'. Together they form a unique fingerprint.